Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Signs of hope? Scientists battle against early-onset colon cancer
2+ hour, 31+ min ago (285+ words) As bowel cancer becomes more common among people in their 50s and younger, concerns about early-onset have been magnified by the disease's growing resistance to chemotherapy. But in what could prove to be a hopeful sign for patients, a team of…...
Advancing RNA drug discovery with Cryo-EM
6+ hour, 46+ min ago (506+ words) The perception of RNA as an ‘undruggable’ target is rapidly changing. Advancements in computational instruments, combined with diversification in compound mode of action, have started to produce promising results with the arrival of the first FDA-approved RNA-targeting compound (risdiplam) on…...
Mathematical Modeling Could Balance Tumor Control and Treatment Toxicity in Melanoma
4+ hour, 28+ min ago (318+ words) New research from The University of Texas at Arlington helps explain a longstanding puzzle in melanoma treatment: why continuous targeted therapy performed better than planned on-and-off treatment schedules in clinical trials, despite promising laboratory studies of intermittent dosing. “Reducing toxicity…...
New Study Explores AI to Predict Immunotherapy Response Across Cancers - Immune Oncology Research Institute - OncoDaily
4+ hour, 9+ min ago (200+ words) Immune Oncology Research Institute shared on LinkedIn: “What if we could know who is most likely to benefit from immunotherapy – before treatment even begins? In a new Nature Medicine study, Wanxiang Shen and colleagues introduce COMPASS, a pan-cancer AI foundation model…...
From COVID vaccines to Neuralink: Inside Dr. Stella Immanuel’s population-control warning
3+ hour, 49+ min ago (568+ words) The COVID-19 pandemic triggered one of the most consequential public-health campaigns in modern history—but it also produced a parallel wave of warnings that the vaccination drive was connected to a much broader agenda involving surveillance, artificial intelligence, human modification…...
World's first oral microbiome-based nanomedicine to supercharge anti-cancer immunity
4+ hour, 4+ min ago (37+ words) Nanowerk World's first oral microbiome-based nanomedicine to supercharge anti-cancer immunity Engineered a DHB prodrug-based oral nano-emulsion with enhanced bioavailability, dramatically improving the efficacy of immune checkpoint blockade therapy....
HLA Protein Technologies’ New NCI License Speeds TCR Immunotherapy and Oncology Discovery
4+ hour, 55+ min ago (57+ words) The Russellville Fire Department stopped by Russellville High School to help the band cool down after marching band practice. Read moreRFD cools down Russellville band practice - New E-Book Details Unprecedented Multi-LLM Collaboration T… Connecticut Democrats face a choice between U.S....
Lyophilisation is growing in pharma, but technical challenges persist
1+ day, 2+ hour ago (891+ words) In Association with Datwyler Lyophilisation solves several challenges in pharmaceutical supply chains while introducing new ones to fill-finish processes. We caught up with Datwyler’s Camille Ermine to discuss freeze drying trends, benefits and difficulties, and how the right packaging decisions…...
Ancient protein C3 helps Japanese scientists beat resistant tumors
19+ hour, 11+ min ago (370+ words) Protein Found Inside Tumors Could Break Therapy Resistance, Japanese Team Reports inkorr.com Protein Found Inside Tumors Could Break Therapy Resistance, Japanese Team Reports An Ancient Protein Takes On Cancer: New Hope for Resistant Tumors Researchers at Japan's Nagoya University…...
SKKU Researchers Develop World???s First Oral Microbiome-Based Nanomedicine to Supercharge Anti-Cancer Immunity
14+ hour, 24+ min ago (475+ words) SKKU Researchers Develop World’s First Oral Microbiome-Based Nanomedicine to Supercharge Anti-Cancer Immunity | Newswise Newswise SKKU Researchers Develop Worldâs First Oral Microbiome-Based Nanomedicine to Supercharge Anti-Cancer Immunity The gut microbial metabolite DHB promotes the formation of antigen-specific, stem-like CD8+ T cells…...